Ovariectomy Exacerbates the Disturbance of Excitation- Inhibition Balance in the Brain of APP/PS-1/tau Mice

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2024 Sep 12

PMID 39262829

Authors

Fuwang Liu

Yanman Liu

Xuri Shen

Jiarui Du

Hanting Zhang

Xueqin Hou

Affiliations

Soon will be listed here.

Abstract

Introduction: The prevalence of Alzheimer's disease (AD) is significantly gender-differentiated, with the number of female AD patients far exceeding that of males, accounting for two-thirds of the total prevalence. Although postmenopausal AD mice have been shown to have more prominent pathologic features and memory impairments than normal AD mice, the relevant molecular mechanisms leading to these outcomes have not been well elucidated. In the present study, we used the disturbance of excitation-inhibition balance in the postmenopausal brain as an entry point to explore the link between estrogen deficiency, disorders of the glutamatergic-GABAergic nervous system, and memory impairment.

Methods: Wild-type (WT) mice and APP/PS1/tau (3 × Tg-AD) mice (10 months old) were randomly divided into four groups: WT+Sham group, WT+OVX group, 3 × Tg-AD+Sham group and 3 × Tg-AD+OVX group. Ovariectomy (OVX) was performed in the WT+OVX group and the 3 × Tg-AD+OVX group, and sham surgery was performed in the WT+Sham group and the 3 × Tg-AD+Sham group. The learning and memory ability and the anxiety and depression-like behavior changes of mice were evaluated by behavioral experiments, and the association between estrogen-estrogen receptors pathway and glutamatergic/GABAergic nervous system and female AD was evaluated by neurochemical experiments.

Results: In WT and 3 × Tg-AD mice, OVX resulted in impaired learning and memory abilities and anxiety and depression-like behaviors; reduced estrogen levels and downregulated the expression of estrogen receptors; upregulated the expression of amyloid-β, amyloid precursor protein, presenilin 1, and p-tau; upregulated the expression of Bcl-2-associated X protein and downregulated the expression of B-cell lymphoma-2, promoting cell apoptosis; reduced the number of neuronal dendrites and downregulated the expression of postsynaptic density protein-95; more importantly, OVX increased brain glutamate levels but downregulated the expression of N-methyl-D-aspartate receptor-2B, excitatory amino acid transporter 1, excitatory amino acid transporter 2, γ-aminobutyric acid receptor-A and γ-aminobutyric acid receptor-B.

Conclusion: Our results suggested that OVX-induced estrogen-estrogen receptors pathway disruption caused learning and memory impairment and anxiety and depression-like behaviors, upregulated the expression of AD pathological markers, promoted apoptosis, destroyed neuronal structure, and most importantly, caused glutamatergic/GABAergic nervous system disorders.

References

Liang Z, Valla J, Sefidvash-Hockley S, Rogers J, Li R . Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J Neurochem. 2002; 80(5):807-14. DOI: 10.1046/j.0022-3042.2002.00779.x. View

Genazzani A, Pluchino N, Luisi S, Luisi M . Estrogen, cognition and female ageing. Hum Reprod Update. 2006; 13(2):175-87. DOI: 10.1093/humupd/dml042. View

Fjell A, McEvoy L, Holland D, Dale A, Walhovd K . What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol. 2014; 117:20-40. PMC: 4343307. DOI: 10.1016/j.pneurobio.2014.02.004. View

Liu G, Wang T, Wang T, Song J, Zhou Z . Effects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomed Rep. 2014; 1(6):861-867. PMC: 3917099. DOI: 10.3892/br.2013.153. View

Yun J, Yeo I, Hwang C, Choi D, Im H, Kim J . Estrogen deficiency exacerbates Aβ-induced memory impairment through enhancement of neuroinflammation, amyloidogenesis and NF-ĸB activation in ovariectomized mice. Brain Behav Immun. 2018; 73:282-293. DOI: 10.1016/j.bbi.2018.05.013. View

Hu Y, Li H, Li R, Tian Y, Wu Z . Protective effects of Schisandrin B against D-GalN-induced cell apoptosis in human hepatocyte (L02) cells via modulating Bcl-2 and Bax. Bioengineered. 2021; 12(1):7205-7214. PMC: 8806808. DOI: 10.1080/21655979.2021.1979863. View

Roy U, Stute L, Hofling C, Hartlage-Rubsamen M, Matysik J, RoBner S . Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease. Neurobiol Aging. 2017; 62:168-179. DOI: 10.1016/j.neurobiolaging.2017.10.015. View

Blurton-Jones M, Tuszynski M . Estradiol-induced modulation of estrogen receptor-beta and GABA within the adult neocortex: a potential transsynaptic mechanism for estrogen modulation of BDNF. J Comp Neurol. 2006; 499(4):603-12. DOI: 10.1002/cne.21122. View

Sharma K, Mehra R . Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax. Brain Res. 2008; 1204:1-15. DOI: 10.1016/j.brainres.2008.01.080. View

10.

Salwierz P, Davenport C, Sumra V, Iulita M, Ferretti M, Tartaglia M . Sex and gender differences in dementia. Int Rev Neurobiol. 2022; 164:179-233. DOI: 10.1016/bs.irn.2022.07.002. View

11.

Wickens M, Bangasser D, Briand L . Sex Differences in Psychiatric Disease: A Focus on the Glutamate System. Front Mol Neurosci. 2018; 11:197. PMC: 5996114. DOI: 10.3389/fnmol.2018.00197. View

12.

Yang J, Wang Z, Cai H, Yuan L, Hu M, Wu M . Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease. Neurosci Bull. 2018; 34(5):736-746. PMC: 6129237. DOI: 10.1007/s12264-018-0268-9. View

13.

Babiloni-Chust I, Dos Santos R, Medina-Gali R, Perez-Serna A, Encinar J, Martinez-Pinna J . G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ERα and ERβ in pancreatic beta cells. Environ Int. 2022; 164:107250. DOI: 10.1016/j.envint.2022.107250. View

14.

Fuentes N, Silveyra P . Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol. 2019; 116:135-170. PMC: 6533072. DOI: 10.1016/bs.apcsb.2019.01.001. View

15.

Xu Y, Zhao M, Han Y, Zhang H . GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment. Front Neurosci. 2020; 14:660. PMC: 7344222. DOI: 10.3389/fnins.2020.00660. View

16.

Depypere H, Vergallo A, Lemercier P, Lista S, Benedet A, Ashton N . Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease. Alzheimers Dement. 2022; 19(4):1320-1330. DOI: 10.1002/alz.12759. View

17.

Karki P, Smith K, Johnson Jr J, Lee E . Astrocyte-derived growth factors and estrogen neuroprotection: role of transforming growth factor-α in estrogen-induced upregulation of glutamate transporters in astrocytes. Mol Cell Endocrinol. 2014; 389(1-2):58-64. PMC: 4040305. DOI: 10.1016/j.mce.2014.01.010. View

18.

Barth C, Crestol A, de Lange A, Galea L . Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's disease. Lancet Diabetes Endocrinol. 2023; 11(12):926-941. DOI: 10.1016/S2213-8587(23)00224-3. View

19.

Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D . Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020; 5(12):e661-e671. DOI: 10.1016/S2468-2667(20)30185-7. View

20.

Zhang M, Liu L, Xu Y, Wang W, Qiu N, Zhang F . Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer disease. Metab Brain Dis. 2023; 38(7):2465-2476. DOI: 10.1007/s11011-023-01242-2. View